4//SEC Filing
Beeler Brian K 4
Accession 0001209191-21-002412
CIK 0001492426other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:07 PM ET
Size
17.4 KB
Accession
0001209191-21-002412
Insider Transaction Report
Form 4
Beeler Brian K
EVP, General Counsel
Transactions
- Award
Restricted Stock Units (RSU)
2021-01-04+24,449→ 24,449 total→ Ordinary Shares (24,449 underlying) - Exercise/Conversion
Ordinary Shares
2021-01-05+39,196→ 103,224 total - Tax Payment
Ordinary Shares
2021-01-05$73.28/sh−44,185$3,237,877→ 119,352 total - Exercise/Conversion
Restricted Stock Units (RSU)
2021-01-05−12,261→ 12,261 total→ Ordinary Shares (12,261 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2021-01-05−17,260→ 0 total→ Ordinary Shares (17,260 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2021-01-05−9,675→ 19,352 total→ Ordinary Shares (9,675 underlying) - Award
Ordinary Shares
2021-01-05+60,313→ 163,537 total
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- [F2]On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2021, the PSUs vested as to the number of shares reported above.
- [F3]The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
- [F4]The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
- [F5]The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001641580
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:07 PM ET
- Size
- 17.4 KB